This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

3 Stocks Reporting Earnings Next Week With Bullish Short Trends

We continue to look for ways to get involved during earnings season. If you are trying to do the same, this list might be a helpful starting point. [More lists:  Hedge Funds Are Cautious Of These 4 Auto Companies]

We started with a list of stocks expected to report earnings next week. We then screened for bullish short trends, with significant decreases in shares shorted month-over-month. We were left with the 3 stocks listed below.

But why the bullish short trends? We went further to look for fundamental catalysts for these companies.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

‚Äč

Tool provided by  Kapitall . Login to access free research tools, share practice portfolios, and more. 

Do you think these stocks will outperform like short sellers expect? Use this list as a starting point for your own analysis.

 

1. Abiomed Inc. ( ABMD): Engages in the research, development, and sale of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Market cap at $547.45M, most recent closing price at $13.80. 

Shares shorted have decreased from 8.59M to 7.61M over the last month, a decrease which represents about 2.82% of the company's float of 34.72M shares. Days to cover ratio at 7.02 days. The company is expected to report earnings on February 6th, 2013.

Investors are now focusing on any new information on management's progress towards submitting the Pre-Market Approval (PMA) application for its miniature heart pump. The product will have to go through a more rigorous process at the FDA, versus the less 510K clearance approval.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,410.23 +218.86 1.27%
S&P 500 2,015.68 +13.52 0.68%
NASDAQ 4,668.4640 +30.47 0.66%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs